Pediatric Ulcerative Colitis

This information is useful for children
Dr. Dinesh Pashankar talks with a teenaged patient.

Credit: Robert A. Lisak

Why Yale Medicine?
  • Our remission rates are higher than national averages for pediatric ulcerative colitis.
  • We offer comprehensive management of pediatric inflammatory bowel diseases.
  • We offer the latest, most advanced treatments and access to clinical trials, which can give patients access to therapies not yet available to others.

Ulcerative colitis—a condition that causes swelling and sores in the colon—is awful for anyone, but especially children, whose symptoms tend to be worse.

With proper treatment, however, children with ulcerative colitis can live happy, healthy lives. A better understanding of this chronic disease will lead to even better therapies.

“Ulcerative colitis is much more severe and aggressive in kids compared to adults,” says Dinesh Pashankar, MD, director of Yale Medicine’s Pediatric Inflammatory Bowel Disease (IBD) Program. “It often involves more of the colon, and the younger the child—particularly those under age 10—the more serious the condition can be.”

Yale Medicine’s IBD team includes doctors, surgeons, nurses, a social worker and a dietitian, all skilled at treating children with IBD. And Yale School of Medicine is one of only six genetic research centers supported by the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) seeking to advance the discovery of genes influencing an individual’s risk for developing ulcerative colitis and Crohn’s disease.